Cladribine Tablets Show Promising Results In Multiple Sclerosis Therapy
The cure for Multiple Sclerosis has once again been put to the spotlight as Merck KGaA, Darmstadt, Germany, a leading science and technology company, operating as EMD Serono in Canada has recently announced the findings obtained from their comprehensive study. The analysis has shown that Cladribine Tablets has demonstrated promising results as it has been found to have reduced the annualized rate of brain volume loss, which is usually referred to as brain atrophy, as compared with placebo in patients with relapsing remitting multiple sclerosis (RRMS). Experts said that the primary endpoint was the relapse rate of over 96 weeks; while the secondary endpoints were noted to have included MRI endpoints, proportion of subjects relapse-free, as well as disability progression at 96 weeks.
Cladribine Tablets In Multiple Sclerosis
Long before, Multiple sclerosis (MS) has been regarded as a chronic, inflammatory condition of the central nervous system and is the most common, non-traumatic, disabling neurological disease in young adults. According to reports revealed by CNW Online, experts have revealed that Cladribine Tablets is basically an investigational short-course oral therapy that selectively and periodically targets lymphocytes that are thought to be integral to the pathological process of MS. As of the press time, Cladribine Tablets is under clinical investigation and has not yet been approved for the treatment for any use in the United States, Canada and Europe.
The Study Involving Cladribine Tablets
Meanwhile, in one of her statements reported by MPR Online, study lead author and associate professor of neurology at the University of Siena, Nicola De Stefano said that the analysis obtained in the their study plays an important role because it confirms the link between reduced brain atrophy and reduced disability progression found in the study. The associate professor also said that the findings support the existing research which indicates that increased brain volume loss over time is associated with worse clinical outcomes, such as increased disability progression and cognitive changes, particularly in MS patients.
Furthermore, it was found that Cladribine Tablets are still in the process of being evaluated in a clinical development program and are yet to be approved for the treatment of any condition in the U.S. Additionally, with regards to the findings from the study, Merck CMO Steven Hildemann said that the findings will be able to make this investigational therapy available for patients living with relapse remitting multiple sclerosis.
HIV Progression Might Be Influenced By Genetics
As HIV has long been noted to be a communicable disease, what’s the truth behind the claims that the rate of speed of the virus’ progression may be influenced by the genetic component of the patient and the virus itself? If so, are there certain measures that a patient can do to slow down its progress? Here’s what health professionals have to say
Health Experts Alarmed About The Rise In STD Cases In South Carolina
Considering the ever growing cases of HIV/Aids all over the world, what's the truth behind claims that health experts have expressed their fear and concern over the rise in teen STD rate? Does this rise in number imply something significant? Here's what health professionals have to say
Congenital Muscular Dystrophy: Everything You Need To Know About The New Condition
Considering the fact that muscular dystrophy is a hereditary condition, how could our genetic component undergo the process of mutation? What’s the truth behind claims that because of this mutation, a new congenital muscular dystrophy has emerged? Is there still hope? Find out what experts have to say
Germany Court Says Tesla's Use of 'Autopilot' is 'Misleading' as It Isn't What They Claimed It To Be
Many people think that the innovative Autopilot system of Tesla is one of the greatest vehicle innovations of modern times. It seems that Germany thinks Tesla saying their system is Autopilot is misleading.
Volkswagen's Recent Racist Ad Sparks Heat Online After Ending Spelled the German "N" Word
Volkswagen's recent ad has been gaining heat for racist "undertones" as the ending spells the German "N" word.
MORE IN ITECHPOST
Cybersecurity: The Top 3 Biggest Data Threats E-Commerce Businesses Face
When you make the decision to start your own business, you know you have to accept the good with the bad of it all. In that acceptance, there’s the potential to achieve great success and make more money than you ever dreamed but there are also certain threats posed against your business that can throw everything down the drain… But that’s just a risk you’re going to have to be willing to take.
[Watch] NASA Announces Week Update: What Happened to the Artemis Program?
Could we be closer to getting to the moon? NASA provides updates on the progress.
Minecraft Dungeons Jungle Awakens Guide: How You Can Easily Defeat The Jungle Abomination
The Jungle Awakens DLC for Minecraft Dungeons brings the destructive enemy boss, the Jungle Abomination. Here is how you can quickly defeat it.